Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR16456
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Tossavainen, Helena; Pihalajamaa, Tero; Huttenen, Toni; Raulo, Erkki; Rauvala, Heikki; Permi, Perttu; Kilperlainen, Ilkka. "The layered fold of the TSR domain of P. falciparum TRAP contains a heparin binding site" Protein Sci. 15, 1760-1768 (2006).
PubMed: 16815922
Assembly members:
TRAP-TSR, polymer, 49 residues, Formula weight is not available
heparin, polymer, 225 residues, 24745.02 Da.
Natural source: Common Name: E. coli Taxonomy ID: 562 Superkingdom: Eubacteria Kingdom: not available Genus/species: Escherichia coli
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: na
Entity Sequences (FASTA):
TRAP-TSR: GSASCGVWDEWSPCSVTCGK
GTRSRKREILHEGCTSEIQE
QCEEERCPP
heparin: IVGGRKARPRQFPFLASIQN
QGRHFCGGALIHARFVMTAA
SCFQSQNPGVSTVVLGAYDL
RRRERQSRQTFSISSMSENG
YDPQQNLNDLMLLQLDREAN
LTSSVTILPLPLQNATVEAG
TRCQVAGWGSQRSGGRLSRF
PRFVNVTVTPEDQCRPNNVC
TGVLTRRGGICNGDGGTPLV
CEGLAHGVASFSLGPCGRGP
DFFTRVALFRDWIDGVLNNP
GPGPA
Data type | Count |
binding constants | 8 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | TRAP-TSR | 1 |
2 | heparin | 2 |
Entity 1, TRAP-TSR 49 residues - Formula weight is not available
1 | GLY | SER | ALA | SER | CYS | GLY | VAL | TRP | ASP | GLU | ||||
2 | TRP | SER | PRO | CYS | SER | VAL | THR | CYS | GLY | LYS | ||||
3 | GLY | THR | ARG | SER | ARG | LYS | ARG | GLU | ILE | LEU | ||||
4 | HIS | GLU | GLY | CYS | THR | SER | GLU | ILE | GLN | GLU | ||||
5 | GLN | CYS | GLU | GLU | GLU | ARG | CYS | PRO | PRO |
Entity 2, heparin 225 residues - 24745.02 Da.
1 | ILE | VAL | GLY | GLY | ARG | LYS | ALA | ARG | PRO | ARG | ||||
2 | GLN | PHE | PRO | PHE | LEU | ALA | SER | ILE | GLN | ASN | ||||
3 | GLN | GLY | ARG | HIS | PHE | CYS | GLY | GLY | ALA | LEU | ||||
4 | ILE | HIS | ALA | ARG | PHE | VAL | MET | THR | ALA | ALA | ||||
5 | SER | CYS | PHE | GLN | SER | GLN | ASN | PRO | GLY | VAL | ||||
6 | SER | THR | VAL | VAL | LEU | GLY | ALA | TYR | ASP | LEU | ||||
7 | ARG | ARG | ARG | GLU | ARG | GLN | SER | ARG | GLN | THR | ||||
8 | PHE | SER | ILE | SER | SER | MET | SER | GLU | ASN | GLY | ||||
9 | TYR | ASP | PRO | GLN | GLN | ASN | LEU | ASN | ASP | LEU | ||||
10 | MET | LEU | LEU | GLN | LEU | ASP | ARG | GLU | ALA | ASN | ||||
11 | LEU | THR | SER | SER | VAL | THR | ILE | LEU | PRO | LEU | ||||
12 | PRO | LEU | GLN | ASN | ALA | THR | VAL | GLU | ALA | GLY | ||||
13 | THR | ARG | CYS | GLN | VAL | ALA | GLY | TRP | GLY | SER | ||||
14 | GLN | ARG | SER | GLY | GLY | ARG | LEU | SER | ARG | PHE | ||||
15 | PRO | ARG | PHE | VAL | ASN | VAL | THR | VAL | THR | PRO | ||||
16 | GLU | ASP | GLN | CYS | ARG | PRO | ASN | ASN | VAL | CYS | ||||
17 | THR | GLY | VAL | LEU | THR | ARG | ARG | GLY | GLY | ILE | ||||
18 | CYS | ASN | GLY | ASP | GLY | GLY | THR | PRO | LEU | VAL | ||||
19 | CYS | GLU | GLY | LEU | ALA | HIS | GLY | VAL | ALA | SER | ||||
20 | PHE | SER | LEU | GLY | PRO | CYS | GLY | ARG | GLY | PRO | ||||
21 | ASP | PHE | PHE | THR | ARG | VAL | ALA | LEU | PHE | ARG | ||||
22 | ASP | TRP | ILE | ASP | GLY | VAL | LEU | ASN | ASN | PRO | ||||
23 | GLY | PRO | GLY | PRO | ALA |
sample_1: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; D2O 6%; H2O 94%
sample_2: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 0.1 mM; D2O 6%; H2O 94%
sample_3: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 0.2 mM; D2O 6%; H2O 94%
sample_4: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 0.3 mM; D2O 6%; H2O 94%
sample_5: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 0.4 mM; D2O 6%; H2O 94%
sample_6: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 0.6 mM; D2O 6%; H2O 94%
sample_7: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 1.25 mM; D2O 6%; H2O 94%
sample_8: TRAP-TSR, [U-13C; U-15N], 0.5 mM; bis-Tris buffer 20 mM; heparin 1.9 mM; D2O 6%; H2O 94%
sample_conditions_1: pH: 6.6; pressure: 1 atm; temperature: 283 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_2 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_3 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_4 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_5 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_6 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_7 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_8 | isotropic | sample_conditions_1 |
SPARKY, Goddard - processing
CYANA, Guntert, Mumenthaler and Wuthrich - structure solution
AMBER v8, Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm - energy minimization
ProcheckNMR, Laskowski and MacArthur - data analysis
Molmol, Koradi, Billeter and Wuthrich - visualization
PDB | |
DBJ | BAA31173 BAA31174 BAA31178 BAA31191 BAA31192 |
EMBL | CAA31440 CAE46497 CAA41601 |
GB | AAA29774 AAC18657 AAW78130 AAW78131 AAW78136 AAB59353 AAH44940 AAH69495 AAH93931 AAH93933 |
PRF | 1411304A 1708291A 1617124A |
SP | P16893 P20160 |
REF | NP_001691 XP_003813807 XP_004059659 XP_009432518 XP_524023 |
AlphaFold | P16893 P20160 |